Journal ArticleJ Clin Pathol · October 17, 2025
AIMS: For phyllodes tumours (PT), local and distant recurrence rates increase with higher grades and are difficult to predict. The Singapore nomogram has been used to predict recurrence events for PT. We aimed to test this nomogram for accuracy in a US coh ...
Full textLink to itemCite
Journal ArticleJ Surg Res · October 9, 2025
INTRODUCTION: Advances in systemic therapy for de novo metastatic breast cancer (dnMBC) led to the development of a novel staging system (IVA-D), which stratifies patients into prognostic subgroups based on tumor characteristics and metastatic extent. Over ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · October 2025
BACKGROUND: Malignant phyllodes tumors (MPT) are biologically aggressive breast neoplasms, with high local and distant recurrence rates and a median survival of 12 months when metastatic. With a disease-free interval often less than 2 years, circulating tu ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · October 2025
INTRODUCTION: Metaplastic breast cancer (MpBC) is a rare breast cancer subtype historically less responsive to neoadjuvant chemotherapy (NAC), regardless of receptor status. Given increasing NAC administration in recent years, we analyzed contemporary trea ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · September 23, 2025
BACKGROUND: De-escalation of axillary surgery for hormone receptor-positive breast cancer has gained traction, but guidelines for axillary management after neoadjuvant endocrine therapy (NET) remain ill-defined. METHODS: Female patients age ≥50 years with ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · September 20, 2025
BACKGROUND: The COVID-19 pandemic restricted operating room availability, prompting the Pandemic Breast Cancer Consortium to issue guidelines on deferring non-urgent surgical procedures. This led to an increased use of neoadjuvant endocrine therapy (NET) f ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · August 2025
BACKGROUND: Contralateral axillary metastasis (CAM) is a rare event and is considered stage IV disease. We sought to evaluate outcomes in a CAM cohort treated with curative intent and contemporary systemic and locoregional therapy. PATIENTS AND METHODS: A ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · June 6, 2025
BACKGROUND: We examined whether adjuvant radiation therapy (RT) monotherapy offers comparable overall survival (OS) to adjuvant endocrine therapy (ET) monotherapy following lumpectomy in women aged ≥ 65 years with favorable early stage breast cancer. PATIE ...
Full textLink to itemCite
Journal ArticleJAMA Netw Open · June 2, 2025
IMPORTANCE: Racial and ethnic disparities in pathologic complete response (pCR) and overall survival (OS) have been reported in patients with triple-negative breast cancer (TNBC). In addition to socioeconomic factors and access to care, differences in tumo ...
Full textLink to itemCite
Journal ArticleBreast Cancer Res Treat · June 2025
BACKGROUND: The risk of developing breast cancer up to age 80 for women with BRCA1/2 mutations is approximately 69-72%. The risk estimates, however, become labile in the later years of life. Many older BRCA1/2 mutation carriers who have not developed breas ...
Full textLink to itemCite
Journal ArticleCancer · May 15, 2025
PURPOSE: Improvements in systemic therapy have resulted in significant heterogeneity in survival outcomes for metastatic breast cancer patients. As such, recently proposed staging guidelines for de novo metastatic breast cancer stratify patients into four ...
Full textLink to itemCite
Journal ArticleJCO Clin Cancer Inform · March 2025
PURPOSE: Guidelines recommend omission of sentinel lymph node biopsy (SLNB) for axillary staging in select patients age 70 years and older with early-stage estrogen receptor-positive (ER+), human epidermal growth factor receptor 2 neu-negative (HER2-) inva ...
Full textLink to itemCite
Journal ArticleJAMA Netw Open · February 3, 2025
IMPORTANCE: Current practices in axillary treatment for patients with breast cancer who receive a mastectomy for node-positive disease are unknown. For patients who receive postmastectomy radiotherapy (PMRT), the addition of axillary lymph node dissection ...
Full textLink to itemCite
Journal ArticleBreast Cancer Res Treat · January 2025
PURPOSE: Germline genetic mutations in women with phyllodes tumors (PT) are understudied, although some describe associations of PT with various mutations. We sought to determine the prevalence of pathogenic/likely pathogenic (P/LP) variants in women with ...
Full textLink to itemCite
ConferenceOncologist · December 6, 2024
BACKGROUND: Malignant phyllodes tumors (MPT) are rare fibroepithelial breast cancers with no known effective systemic therapy; metastatic progression portends a dismal prognosis. We sought to describe the genomic landscape of MPTs through genomic profiling ...
Full textLink to itemCite
ConferenceAnn Surg Oncol · December 2024
BACKGROUND: Axillary management after neoadjuvant chemotherapy (NAC) is evolving but axillary lymph node dissection (ALND) remains the standard of care for patients with residual nodal disease. The results of the Alliance A011202 trial evaluating the oncol ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · December 2024
BACKGROUND: Older breast cancer patients represent a heterogeneous population. Studies demonstrate that sentinel lymph node biopsy (SLNB) omission may be appropriate in some clinical scenarios, yet patients with triple-negative breast cancer (TNBC) are oft ...
Full textLink to itemCite
Journal ArticleJCO Precis Oncol · December 2024
PURPOSE: Malignant phyllodes tumors (MPTs) are rare fibroepithelial tumors of the breast with aggressive biologic behavior and high recurrence rates. Surgery remains the primary treatment modality for these tumors; however, initial investigations suggest a ...
Full textLink to itemCite
ConferenceAnn Surg Oncol · November 2024
BACKGROUND: Patients with inflammatory breast cancer (IBC) have worse survival compared with stage III non-IBC matched cohorts; however, the prognostic significance of achieving pathologic complete response (pCR) in the setting of IBC is not well described ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · October 2024
BACKGROUND: The utility of sentinel lymph node biopsy (SLNB) in older patients remains controversial. Advancements in human epidermal growth factor receptor 2 (HER2)-directed therapy have revolutionized disease response rates and prognosis, supporting effo ...
Full textLink to itemCite
Chapter · September 24, 2024
Due to tremendous advancements in breast cancer screening techniques, we now have the ability to detect breast cancer at earlier stages of disease. Often times, the cancer can be identified before the patient is able to palpate a mass. Localization of thes ...
Full textCite
Journal ArticleSurgical Oncology Insight · September 1, 2024
Introduction: Approximately 5 % of patients with new breast cancer diagnoses have stage IV disease and 10 % of these patients have liver-confined metastases. The surgical management of synchronous liver metastases remains controversial. Methods: The Nation ...
Full textCite
Journal ArticleBMJ Case Rep · July 3, 2024
Malignant phyllodes tumours (PTs) are aggressive neoplasms with high rates of local recurrence and distant metastasis. With no known effective chemotherapy and no approved targeted therapy in the setting of metastatic disease, prognosis is limited with an ...
Full textLink to itemCite
Journal ArticleAm J Surg · July 2024
BACKGROUND: The predictive and prognostic value of the recurrence score (RS) has emphasized the importance of tumor biology and has reduced the prognostic implications of limited nodal burden in post-menopausal women with HR+/HER2-invasive breast cancer (I ...
Full textLink to itemCite
Journal ArticleJ Natl Compr Canc Netw · July 2024
Breast cancer is treated with a multidisciplinary approach involving surgical oncology, radiation oncology, and medical oncology. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Breast Cancer include recommendations for clinical man ...
Full textLink to itemCite
Journal ArticleJAMA Oncol · June 1, 2024
IMPORTANCE: Data on oncological outcomes after omission of axillary lymph node dissection (ALND) in patients with breast cancer that downstages from node positive to negative with neoadjuvant chemotherapy are sparse. Additionally, the best axillary surgica ...
Full textLink to itemCite
Journal ArticleJ Clin Oncol · May 10, 2024
PURPOSE: Black women have higher rates of death from triple-negative breast cancer (TNBC) than White women. We hypothesized that pathologic complete response (pCR) to neoadjuvant chemotherapy (NAC) and overall survival (OS) may vary by race/ethnicity in pa ...
Full textLink to itemCite
Journal ArticleJ Surg Res · April 2024
INTRODUCTION: With the increasing utilization of genomic assays, such as the Oncotype DX recurrence score (RS), the relevance of anatomic staging has been questioned for select older patients with breast cancer. We sought to evaluate differences in chemoth ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · October 2023
BACKGROUND: Benefits of a pathologic complete response (pCR) following neoadjuvant therapy are well established, yet outcomes for older women are understudied. We sought to examine the pCR and overall survival (OS) rates of women with estrogen receptor (ER ...
Full textLink to itemCite
Journal ArticleJ Natl Compr Canc Netw · June 2023
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Breast Cancer address all aspects of management for breast cancer. The treatment landscape of metastatic breast cancer is evolving constantly. The therapeutic strategy takes into consi ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · April 2023
BACKGROUND: Initial trials evaluating Oncotype DX, reported as a recurrence score (RS) from 0 to 100, were not powered to evaluate overall survival, and premenopausal women were underrepresented. The purpose of this study was to explore the benefit of chem ...
Full textLink to itemCite
Journal ArticleJ Surg Oncol · March 2023
BACKGROUND AND OBJECTIVES: Previous studies have identified racial-ethnic differences in the diagnostic patterns and recurrence outcomes of women with phyllodes tumors (PT). However, these studies are generally limited in size and generalizability. We ther ...
Full textLink to itemCite
ConferenceCancer Research · March 1, 2023
AbstractBackground: The predictive and prognostic value of the 21-gene recurrence score (RS) has emphasized the importance of tumor biology and minimized the credence of a limited (1-3 positive) nodal burden ...
Full textCite
ConferenceCancer Research · March 1, 2023
AbstractIntroduction: Despite the recent overall improvement in survival for patients with breast cancer, racial disparities in outcomes persist. While studies have demonstrated that socioeconomic factors an ...
Full textCite
ConferenceAm J Surg · January 2023
BACKGROUND: We investigated whether tumor phenotype influences surgical decision-making, and how that may impact overall survival (OS) for early-stage breast cancer. METHODS: Women aged 18-69 with cT0-2/cN0/cM0 breast cancer in the National Cancer Database ...
Full textLink to itemCite
Chapter · January 1, 2023
Inflammatory breast cancer (IBC) is a rare presentation of locally advanced breast cancer. Although the incidence is 1% to 3%, IBC has a disproportionally dismal prognosis with a 5-year survival rate of 41% overall in the United States. IBC is a clinical d ...
Full textCite
ConferenceAnn Surg Oncol · October 2022
BACKGROUND: Multiple studies have demonstrated a link between obesity and breast cancer; however, the potential association between obesity and atypical high-risk breast lesions has not been well characterized. We sought to evaluate the characteristics and ...
Full textLink to itemCite
ConferenceAnn Surg Oncol · October 2022
BACKGROUND: Phyllodes tumors (PTs) are rare breast neoplasms with variable clinical behavior by histologic type: benign, borderline, or malignant. Until recently, management guidelines recommended one approach for all subtypes. METHODS: A 21-question surve ...
Full textLink to itemCite
Journal ArticleCurrent Breast Cancer Reports · September 1, 2022
Purpose of review: De novo metastatic breast cancer (dnMBC) accounts for approximately 6% of all new breast cancers each year. While the survival benefits from removing the primary tumor in patients with MBC remain unclear, many patients still undergo surg ...
Full textCite
Journal ArticleJ Natl Compr Canc Netw · June 2022
The therapeutic options for patients with noninvasive or invasive breast cancer are complex and varied. These NCCN Clinical Practice Guidelines for Breast Cancer include recommendations for clinical management of patients with carcinoma in situ, invasive b ...
Full textLink to itemCite
Journal ArticleJCO Oncol Pract · May 2022
PURPOSE: We sought to examine tumor subtype, stage at diagnosis, time to surgery (TTS), and overall survival (OS) among Hispanic patients of different races and among Hispanic and non-Hispanic (NH) women of the same race. METHODS: Women 18 years of age or ...
Full textLink to itemCite
ConferenceJ Surg Oncol · May 2022
BACKGROUND: Malignant phyllodes (MP) and primary breast sarcomas (PBS) are rare neoplasms with overlapping histopathologic features. We compared overall survival (OS) and estimated the association of surgery and therapies with OS. METHODS: We utilized the ...
Full textLink to itemCite
Journal ArticleJ Am Coll Surg · May 1, 2022
BACKGROUND: Breast angiosarcoma is a rare malignancy classically associated with hematogenous metastases. We sought to determine the prevalence of pathologic nodal involvement in patients with nonmetastatic, resected breast angiosarcoma and its association ...
Full textLink to itemCite
Journal ArticleAnn Surg · April 1, 2022
OBJECTIVE: We aim to identify prognostic groups within a de novo metastatic cohort, incorporating both anatomic and biologic factors. BACKGROUND: Staging for breast cancer now includes anatomic and biologic factors, although the guidelines for stage IV dis ...
Full textLink to itemCite
Journal ArticleJAMIA Open · April 2022
OBJECTIVE: Surgical instrument oversupply drives cost, confusion, and workload in the operating room. With an estimated 78%-87% of instruments being unused, many health systems have recognized the need for supply refinement. By manually recording instrumen ...
Full textLink to itemCite
ConferenceCancer · March 1, 2022
BACKGROUND: Asian women with breast cancer are often studied in aggregate, belying significant intragroup diversity. The authors sought to examine differences in breast cancer characteristics and outcomes among Asian women. METHODS: Asian, non-Hispanic Bla ...
Full textLink to itemCite
Journal ArticleCancer Med · February 2022
BACKGROUND: Controversy exists regarding the optimal sequence of chemotherapy among women with operable node-negative breast cancers with high-risk tumor biology. We evaluated national patterns of neoadjuvant chemotherapy (NACT) use among women with early- ...
Full textLink to itemCite
Journal ArticleBr J Surg · December 1, 2021
BACKGROUND: This study aimed to determine the impact of pulmonary complications on death after surgery both before and during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. METHODS: This was a patient-level, comparative analysis ...
Full textLink to itemCite
ConferenceAnnals of surgical oncology · November 2021
BackgroundAlthough metastatic breast cancer (MBC) remains incurable, advances in therapies have improved survival. Using a contemporary dataset of de novo MBC patients, we explore how overall (OS) and cancer-specific survival (CSS) changed over ti ...
Full textCite
Journal ArticleAnn Surg Oncol · November 2021
BACKGROUND: Phyllodes tumors are rare fibroepithelial neoplasms that are classified by tiered histopathologic features. While there are protocols for the reporting of cancer specimens, no standardized reporting protocol exists for phyllodes. METHODS: We pe ...
Full textLink to itemCite
Journal ArticleLancet Oncol · November 2021
BACKGROUND: Surgery is the main modality of cure for solid cancers and was prioritised to continue during COVID-19 outbreaks. This study aimed to identify immediate areas for system strengthening by comparing the delivery of elective cancer surgery during ...
Full textLink to itemCite
ConferenceAnn Surg Oncol · October 2021
BACKGROUND: Breast surgery carries a low risk of postoperative mortality. For older patients with multiple comorbidities, even low-risk procedures can confer some increased perioperative risk. We sought to identify factors associated with postoperative mor ...
Full textLink to itemCite
ConferenceAnnals of surgical oncology · October 2021
BackgroundContralateral axillary nodal metastases (CAM) is classified as stage IV disease, although many centers treat CAM with curative intent. We hypothesized that patients with CAM, treated with multimodality therapy, would have improved overal ...
Full textCite
Journal ArticleJ Surg Res · August 2021
BACKGROUND: Surgical instrument tray reduction attempts to minimize intraoperative inefficiency and processing costs. Previous reduction methods relied on trained observers manually recording instrument use (i.e. human ethnography), and surgeon and/or staf ...
Full textLink to itemCite
ConferenceCancer · July 15, 2021
BACKGROUND: The North Carolina Breast and Cervical Cancer Control Program (NC BCCCP) provides breast cancer screening services to underserved women to mitigate disparities in access to care. The authors sought to characterize this understudied population. ...
Full textLink to itemCite
Journal ArticleAnnals of surgical oncology · May 2021
BackgroundAvailable retrospective data suggest the upgrade rate for intraductal papilloma (IP) without atypia on core biopsy (CB) ranges from 0 to 12%, leading to variation in recommendations. We conducted a prospective multi-institutional trial ( ...
Full textCite
Journal ArticleAnn Surg Oncol · April 2021
BACKGROUND: In 2002, breast cancer patients with supraclavicular nodal metastases (cN3c) were downstaged from AJCC stage IV to IIIc, prompting management with locoregional treatment. We sought to estimate the impact of multimodal therapy on overall surviva ...
Full textLink to itemCite
Journal ArticleBreast Cancer Res Treat · April 2021
PURPOSE: Time to surgery (TTS) is a potentially modifiable factor associated with survival after breast cancer diagnosis and can serve as a proxy for quality of oncologic care coordination. We sought to determine whether factors associated with delays in T ...
Full textLink to itemCite
Journal ArticleJ Clin Oncol · January 20, 2021
PURPOSE: Phyllodes tumors (PTs) are rare breast neoplasms, which have little granular data on margins. Current guidelines recommend ≥ 1 cm margins; however, recent data suggest narrower margins are sufficient, and for benign PT, a negative margin may not b ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · November 2020
BACKGROUND: Men represent a small proportion of breast cancer diagnoses, and they are often excluded from clinical trials. Current treatments are largely extrapolated from evidence in women. We compare practice patterns between men and women with breast ca ...
Full textLink to itemCite
ConferenceAnn Surg Oncol · October 2020
BACKGROUND: A paucity of data exists regarding inherited mutations associated with phyllodes tumors (PT); however, some are reported (TP53, BRCA1, and RB1). A PT diagnosis does not meet NCCN criteria for testing, including within Li-Fraumeni Syndrome (TP53 ...
Full textLink to itemCite
Journal ArticleJ Surg Res · October 2020
BACKGROUND: Elderly women with clinically node-positive (cN+) breast cancer (BC) often have comorbidities that limit life expectancy and complicate treatment. We sought to determine whether the number of lymph nodes (LNs) retrieved among older women with n ...
Full textLink to itemCite
Journal ArticlePlast Reconstr Surg · March 2020
BACKGROUND: Breast cancer survival continues to improve, with women living longer after treatment. It is not well understood how long-term satisfaction and well-being differ following treatment or how types of reconstruction differ when compared to the nor ...
Full textLink to itemCite
ConferenceCancer Research · February 15, 2020
AbstractBackground: Meta-analyses have demonstrated that young women ≤40 (YW) derive the most benefit from chemotherapy (EBCTCG, Lancet. 1998). Oncotype DX was designed to determine the benefit of chemothera ...
Full textCite
ConferenceBreast Cancer Res Treat · February 2020
PURPOSE: National guidelines define adequate axillary lymph node dissections as those yielding ≥ 10 lymph nodes (LNs). We aimed to identify the optimal LN yield among node-positive patients. METHODS: Using the National Cancer Data Base (2010-2015), we cate ...
Full textLink to itemCite
ConferenceBreast Cancer Res Treat · February 2020
BACKGROUND: Given presumed differences in disease severity between young (≤ 45 years) and elderly (≥ 75 years) women with breast cancer, we sought to compare tumor histopathology, stage at presentation, patterns of care, and survival at the extremes of age ...
Full textLink to itemCite
Journal ArticleInt J Radiat Oncol Biol Phys · February 1, 2020
BACKGROUND: Pathologic complete response (pCR) after neoadjuvant chemotherapy (NACT) is associated with improved overall survival (OS) in patients with breast cancer, but it is unclear how post-NACT response influences radiation therapy administration in p ...
Full textOpen AccessLink to itemCite
Journal ArticleBreast Cancer Res Treat · February 2020
PURPOSE: Inflammatory breast cancer (IBC) is an aggressive variant for which axillary lymph node (LN) dissection following neoadjuvant chemotherapy (NACT) remains standard of care. But with increasingly effective systemic therapy, it is unclear whether mor ...
Full textLink to itemCite
Journal ArticleAnn Surg · January 2020
OBJECTIVE: We assessed the changes that have resulted from the latest breast cancer staging guidelines and the potential impact on prognosis. BACKGROUND: Contemporary data suggest that combining anatomic staging and tumor biology yields a predictive synerg ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · December 2019
BACKGROUND: Women with dense breasts may have less-accurate preoperative evaluation of extent of disease, potentially affecting the achievement of negative margins. The goal of this study is to examine the association between breast density and re-excision ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · November 2019
BACKGROUND: The Society of Surgical Oncology and American Society for Radiation Oncology consensus guidelines defined a negative margin for breast-conserving surgery (BCS) as no ink on tumor, and implementation has reduced rates of additional surgery for p ...
Full textLink to itemCite
ConferenceAm J Surg · October 2019
BACKGROUND: Sentinel lymph node biopsy has supplanted axillary lymph node dissection (ALND) in clinically node-negative breast cancer and select node-positive disease. We hypothesized a decreasing rate of both ALND and resident exposure over time. METHODS: ...
Full textLink to itemCite
ConferenceAnn Surg Oncol · October 2019
BACKGROUND: Ductal carcinoma in situ (DCIS) with microinvasion (DCISM) can be challenging in balancing the risks of overtreatment versus undertreatment. We compared DCISM, pure DCIS, and small volume (T1a) invasive ductal carcinoma (IDC) as related to hist ...
Full textLink to itemCite
ConferenceAnn Surg Oncol · October 2019
BACKGROUND: Neoadjuvant chemotherapy (NACT) is often recommended for patients with node-positive invasive lobular carcinoma (ILC) despite unclear benefit in this largely hormone receptor-positive (HR+) group. We sought to compare overall survival (OS) betw ...
Full textLink to itemCite
Journal ArticleAm J Surg · October 2019
BACKGROUND: We aim to determine clinical and pathological stage discordance rates and to evaluate factors associated with discordance. METHODS: Adults with clinical stages I-III breast cancer were identified from the National Cancer Data Base. Concordance ...
Full textOpen AccessLink to itemCite
Journal ArticleCurrent Breast Cancer Reports · September 15, 2019
Purpose of Review: Standard treatment for ductal carcinoma in situ (DCIS) is similar to that of invasive carcinoma. However, there is significant controversy regarding the true clinical implications of DCIS, and thus, the best management strategy. The aim ...
Full textCite
Journal ArticleJ Surg Res · September 2019
BACKGROUND: Although several prognostic variables and risk factors for breast cancer are age-related, the association between age and risk of cancer with breast atypia is controversial. This study aimed to compare the type of breast atypia and risk of unde ...
Full textOpen AccessLink to itemCite
Journal ArticleJ Surg Oncol · August 2019
BACKGROUND AND OBJECTIVES: We sought to evaluate the impact of chemotherapy sequence on survival by comparing node-positive invasive lobular carcinoma (ILC) patients who received neoadjuvant (NACT) and adjuvant (ACT) chemotherapy. METHODS: cT1-4c, cN1-3 IL ...
Full textOpen AccessLink to itemCite
Journal ArticleLiver Transpl · July 2019
The appropriate duration of surgical antibiotic prophylaxis in orthotopic liver transplantation (OLT) in the presence of significant iatrogenic immunosuppression is unclear. We hypothesized that 72 hours of perioperative antibiotic prophylaxis would decrea ...
Full textLink to itemCite
Journal ArticleAnn Surg · March 2019
OBJECTIVE: We evaluated patterns of surgical care and their association with overall survival among a contemporary cohort of women with stage IV breast cancer. BACKGROUND: Surgical resection of the primary tumor remains controversial among women with stage ...
Full textLink to itemCite
ConferenceAnn Surg Oncol · October 2018
BACKGROUND: Recent studies suggest that surgical lymph node (LN) evaluation may be omitted in select elderly breast cancer patients as it may not influence adjuvant therapy decisions. To evaluate differences in adjuvant therapy receipt and overall survival ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · October 2018
BACKGROUND: Although surgical management of the axilla for breast cancer continues to evolve, axillary lymphadenectomy remains the standard of care for women with advanced nodal disease. We sought to evaluate national patterns of care in axillary surgery, ...
Full textLink to itemCite
Journal ArticleAnn Surg · October 2018
OBJECTIVE: To determine whether the association between overall survival (OS) and response to neoadjuvant chemotherapy (NACT) in breast cancer patients varies with tumor subtype and anatomic extent of pathologic complete response (pCR). BACKGROUND: pCR aft ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · August 2018
BACKGROUND: Metaplastic breast cancer (MBC) is characterized by chemoresistance and hematogenous spread. We sought to identify factors associated with improved MBC outcomes and increased likelihood of MBC diagnosis. METHODS: Women ≥ 18 years of age with st ...
Full textLink to itemCite
Journal ArticleJ Pediatr Surg · June 2018
BACKGROUND: Phyllodes tumors are fibroepithelial breast lesions that are uncommon in women and rare among children. Due to scarcity, few large pediatric phyllodes tumor series exist. Current guidelines do not differentiate treatment recommendations between ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · November 2017
BACKGROUND: The American College of Surgeons Oncology Group (ACOSOG) Z0011 trial established the safety of omitting axillary lymph node dissection (ALND) for early-stage breast cancer patients with limited nodal disease undergoing lumpectomy. We examined t ...
Full textLink to itemCite
ConferenceJournal of Clinical Oncology · May 20, 2017
532 Background: Metaplastic breast cancer (MBC) is a rare, aggressive variant that is often triple negative (TN). Current guidelines recommend use of standard receptor-based treatment for MBC despite evidence of chemoresistance. ...
Full textCite
ConferenceJournal of Clinical Oncology · May 20, 2017
1570 Background: Metaplastic breast cancer (MBC) is a rare, aggressive, sarcomatoid breast cancer that was first described in 1973 but only became recognized as a histologically distinct entity in 2000. Given the paucity of data ...
Full textCite
ConferenceJournal of Clinical Oncology · May 20, 2017
e18144 Background: Breast oncologists have little guidance on predicting long term outcomes after interval survival. We aim to evaluate the association of overall survival (OS) with select factors at multiple time points. Methods ...
Full textCite
Journal ArticleBreast Cancer Res Treat · April 2017
BACKGROUND: The phrase "high-risk for breast cancer" is used to identify various groups at elevated cancer risk, and the appropriate surveillance and risk-reducing strategies differ based on the etiology of risk. Here, we review the utility of patient-repo ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · October 2016
BACKGROUND: Reexcision rates in patients undergoing breast-conserving surgery (BCS) for early-stage invasive breast cancer are highly variable. The Society of Surgical Oncology (SSO) and American Society for Radiation Oncology (ASTRO) published consensus g ...
Full textLink to itemCite
Journal ArticleJ Pediatr Surg Case Rep · July 2016
We present a case of a 26 week premature newborn with an immature intrapericardial teratoma. The patient was transferred from an outside hospital for management of a large mediastinal mass causing respiratory insufficiency. The newborn was supported with t ...
Full textLink to itemCite
Journal ArticleSurg Infect (Larchmt) · February 2016
BACKGROUND: Overuse of broad-spectrum antibiotics results in microbial resistance and financially is a healthcare burden. Antibiotic de-escalation refers to starting treatment of a presumed infection with broad-spectrum antibiotics and narrowing drug spect ...
Full textLink to itemCite
Journal ArticleSurg Innov · February 2016
BACKGROUND: The percutaneous endoscopic gastrostomy (PEG) is a ubiquitous feeding tube with high rates of accidental dislodgement, with significant morbidity and health care costs. We hypothesized use of a decoupling device is a safe and effective mechanis ...
Full textLink to itemCite
Journal ArticleSurg Infect (Larchmt) · August 2015
BACKGROUND: Blood stream infections (BSIs) are a common source of morbidity and death in hospitalized patients. We hypothesized that the proportions of bacteremia from gram-positive and fungal pathogens have decreased over time, whereas rates of gram-negat ...
Full textLink to itemCite
Journal ArticleAm J Clin Nutr · November 2014
BACKGROUND: Proper caloric intake goals in critically ill surgical patients are unclear. It is possible that overnutrition can lead to hyperglycemia and an increased risk of infection. OBJECTIVE: This study was conducted to determine whether surgical infec ...
Full textLink to itemCite
Journal ArticleSurg Infect (Larchmt) · October 2014
BACKGROUND: Ventilator-associated pneumonia (VAP) is a common healthcare-associated infection affecting as many as 27% of mechanically ventilated patients. Ventilator-associated pneumonia is an important source of morbidity and mortality in the surgical in ...
Full textLink to itemCite
Journal ArticleSurg Infect (Larchmt) · August 2014
BACKGROUND: We hypothesized that a longer duration of antibiotic treatment for intra-abdominal infections (IAI) would be associated with an increased risk of extra-abdominal infections (EAI) and high mortality. METHODS: We reviewed all IAI occurring in a s ...
Full textLink to itemCite
Journal ArticleSurg Infect (Larchmt) · June 2014
BACKGROUND: Aspergillus infections are associated commonly with immunocompromised states, such as transplantation and hematologic malignant disease. Although Aspergillus infections among patients having surgery occur primarily in transplant recipients, the ...
Full textLink to itemCite
Journal ArticleSurg Infect (Larchmt) · April 2014
BACKGROUND: Anastomotic leak after rectal resection carries substantial morbidity and mortality. A diverting ileostomy is beneficial for high-risk anastomoses, but its creation and reversal carry a surgical risk in addition to that of resection itself. We ...
Full textLink to itemCite
Journal ArticleSurg Infect (Larchmt) · April 2014
BACKGROUND: The Donor Risk Index (DRI) is used to predict graft survival following liver transplantation, but has not been used to predict post-operative infections in graft recipients. We hypothesized that lower-quality grafts would result in more frequen ...
Full textLink to itemCite
Journal ArticleClin Transl Sci · April 2014
Anastomotic leaks are a dreaded surgical complication following colorectal operations. Creation of a temporary proximal diverting ileostomy is used in high-risk anastomoses, however, additional surgical risk is accumulated with its creation and reversal. E ...
Full textLink to itemCite
Journal ArticleJ Trauma Acute Care Surg · February 2013
BACKGROUND: Ventilator-associated pneumonia (VAP) is the most common hospital-acquired infection in the intensive care unit, with substantial subsequent mortality. The mortality following VAP declined in the 1980s and 1990s. Experts suggest that little pro ...
Full textLink to itemCite
Journal ArticleSurg Infect (Larchmt) · February 2013
BACKGROUND: The use of silver for the treatment of various maladies or to prevent the transmission of infection dates back to at least 4000 b.c.e. Medical applications are documented in the literature throughout the 17th and 18th centuries. The bactericida ...
Full textLink to itemCite
Journal ArticleJournal of Surgical Radiology · January 1, 2013
Overview: An 85 year-old woman underwent a laparoscopic paraesophageal hernia repair complicated by a delayed esophageal leak. Prior to initiation of tube feeds, a jejunal feeding tube was placed through the existing PEG tube fluoroscopically. Following th ...
Cite
Journal ArticleSurg Infect (Larchmt) · December 2012
BACKGROUND: The infected abdomen poses substantial challenges to surgeons, and often, both temporary and definitive closure techniques are required. We reviewed the options available to close the abdominal wall defect encountered frequently during and afte ...
Full textLink to itemCite
Journal ArticleSurg Laparosc Endosc Percutan Tech · October 2012
A gastropexy with T-fasteners can maintain gastric apposition to the abdominal wall before a mature gastrocutaneous fistula. In patients at high risk for inadvertently removing their percutaneous endoscopic gastrostomy tube, or those in whom early, uninten ...
Full textLink to itemCite
Journal ArticleLancet Infect Dis · October 2012
BACKGROUND: Antimicrobial treatment in critically ill patients can either be started as soon as infection is suspected or after objective data confirm an infection. We postulated that delaying antimicrobial treatment of patients with suspected infections i ...
Full textLink to itemCite
Journal ArticleJ Am Coll Surg · May 2012
BACKGROUND: Resistant pathogens are increasingly common in the ICU, with controversy regarding their relationship to outcomes. We hypothesized that an increasing number of infections with resistant pathogens in our surgical ICU would not be associated with ...
Full textLink to itemCite
Chapter · April 19, 2012
Managing infectious complications in obese critically ill patients presents unique challenges and is associated with significant cost to the health care industry. Generally, obese patients tend to have a higher incidence of blood-stream, catheter-related, ...
Full textCite
Journal ArticleSurg Infect (Larchmt) · April 2012
BACKGROUND: Isolation is defined as the separation of persons with communicable diseases from those who are healthy. This public health practice, along with quarantine, is used to limit the transmission of infectious diseases and provides the foundation of ...
Full textLink to itemCite
Journal ArticleJ Am Coll Surg · April 2012
BACKGROUND: The neuroimmunologic effect of traumatic head injury remains ill-defined. This study aimed to characterize systemic cytokine profiles among traumatically injured patients to assess the effect of traumatic head injury on the systemic inflammator ...
Full textLink to itemCite
Journal ArticleJ Gastrointest Surg · April 2012
BACKGROUND: Intraductal papillary mucinous neoplasm (IPMN) is an increasingly recognized pancreatic neoplasm characterized by excessive mucin secretion by ductal epithelial cells resulting in a cystic dilation of the pancreatic duct. AIM: The objective of ...
Full textLink to itemCite
Journal ArticleObstet Gynecol · February 2012
BACKGROUND: Fifty percent of aortic dissections in women younger than 40 years occur in association with pregnancy. Of these, half of type B dissections occur in the postpartum period. CASE: A 30-year-old woman was status post spontaneous vaginal delivery ...
Full textLink to itemCite
Journal ArticleSurg Infect (Larchmt) · October 2011
BACKGROUND: Cohorting patients in dedicated hospital wards or wings during infection outbreaks reduces transmission of organisms, yet frequently, this may not be feasible because of inadequate capacity, especially in the intensive care unit (ICU). We hypot ...
Full textLink to itemCite
Journal ArticleSurg Endosc · October 2011
BACKGROUND: Since its introduction in 1980, the percutaneous endoscopic gastrostomy (PEG) tube has become an efficient means of providing long-term enteral access. Conveniently, the soft inner bumper allows PEG removal with relatively minimal external trac ...
Full textLink to itemCite
Journal ArticleJ Gastrointest Surg · September 2011
INTRODUCTION: Dorsal agenesis of the pancreas (DAP) is a rare congenital anomaly, with only 44 cases having been reported in the English literature since 1966. MATERIALS AND METHODS: A retrospective review of our IRB-approved pancreatic surgery database wa ...
Full textLink to itemCite
Journal ArticleAm Surg · July 2011
Intra-abdominal infections following surgical procedures result from organ-space surgical site infections, visceral perforations, or anastomotic leaks. We hypothesized that open surgical drainage is associated with increased patient morbidity and mortality ...
Link to itemCite
ConferenceSurg Infect (Larchmt) · June 2011
BACKGROUND: In response to inconsistent compliance with infection prevention measures, the Centers for Medicare & Medicaid Services collaborated with the U.S. Centers for Disease Control and Prevention on the Surgical Infection Prevention (SIP) project, in ...
Full textLink to itemCite
Journal ArticleCrit Care Med · April 2011
OBJECTIVE: Heparin-induced thrombocytopenia is a common adverse effect of treatment with heparin resulting in paradoxical thromboses. An immunoglobulin G class "heparin-induced thrombocytopenia antibody" attaches to a heparin-platelet factor 4 protein comp ...
Full textLink to itemCite